Posted in | News

A NEW PAT FOR WET GRANULATION

Over the past decade the symbiotic nature of Quality by Design (QbD) and Process Analytical Technology (PAT) has become clear. In the simplest of terms QbD systematically identifies what must be measured, and controlled, while PAT provides the necessary measurements, in the required timeframe. Wet granulation, and more specifically high shear wet granulation (HSWG), is a valuable process for the pharmaceutical industry, particularly for the preparation of tableting blends, but it remains challenging from this perspective. There is still debate over what can be most usefully measured and consequently the most appropriate PAT.

Our latest whitepaper, featured in Pharmaceutical Technology, demonstrates the value of dynamic powder flow measurements for the development and optimisation of wet granulation processes, drawing on data from two experimental studies. It shows how:

  • the FT4 Powder Rheometer® can be used to measure granule properties that correlate directly with the Critical Quality Attributes (CQAs) of tablets.
  • the Lenterra Flow Sensor system, a new PAT for real-time measurement, enables complementary, continuous in-line monitoring.

Used together these technologies present an integrated solution for HSWG monitoring and control.

To access your copy please visit the Pharmaceutical Technology website.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Freeman Technology. (2018, September 27). A NEW PAT FOR WET GRANULATION. AZoM. Retrieved on April 20, 2024 from https://www.azom.com/news.aspx?newsID=49725.

  • MLA

    Freeman Technology. "A NEW PAT FOR WET GRANULATION". AZoM. 20 April 2024. <https://www.azom.com/news.aspx?newsID=49725>.

  • Chicago

    Freeman Technology. "A NEW PAT FOR WET GRANULATION". AZoM. https://www.azom.com/news.aspx?newsID=49725. (accessed April 20, 2024).

  • Harvard

    Freeman Technology. 2018. A NEW PAT FOR WET GRANULATION. AZoM, viewed 20 April 2024, https://www.azom.com/news.aspx?newsID=49725.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.